Ciclopirox and Ciclopirox Olamine: Antifungal Agents in Dermatology with Expanding Therapeutic Potential

被引:0
|
作者
Mucha, Paulina [1 ]
Borkowski, Bartlomiej [1 ,2 ]
Erkiert-Polguj, Anna [3 ]
Budzisz, Elzbieta [1 ]
机构
[1] Med Univ Lodz, Fac Pharm, Dept Chem Cosmet Raw Mat, Muszynskiego 1 St, PL-91151 Lodz, Poland
[2] Pharmaceut Works POLPHARMA SA Medana Branch Sierad, Res & Dev Dept, 10 Wladyslawa Lokietka, PL-98200 Sieradz, Poland
[3] Med Univ Lodz, Fac Pharm, Dept Cosmetol & Aesthet Dermatol, Muszynskiego 1 St, PL-91151 Lodz, Poland
来源
APPLIED SCIENCES-BASEL | 2024年 / 14卷 / 24期
关键词
ciclopirox; ciclopirox olamine; CPX; CPO; antifungal; dandruff; dermatology; SEBORRHEIC DERMATITIS; NAIL LACQUER; MALASSEZIA-GLOBOSA; SOLUTION; 8-PERCENT; BACTERIAL; SKIN; MANAGEMENT; 1-PERCENT; EFFICACY; KETOCONAZOLE;
D O I
10.3390/app142411859
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Ciclopirox (CPX) and its ethanolamine salt, ciclopirox olamine (CPO), are synthetic hydroxypyridone derivatives with a wide range of antimicrobial activity, making them valuable in dermatology for treating fungal infections. Their mechanism of action is multifaceted, impacting iron-dependent enzymes and disrupting mitochondrial function, cellular energy production, and membrane integrity. The compounds' favorable physicochemical properties allow effective skin absorption, while the olamine salt enhances solubility and bioavailability. Research is ongoing to explore therapeutic uses beyond dermatology, including applications in autoimmune diseases, cancer, and neurodegenerative disorders. In cosmetics, ciclopirox is used primarily in anti-dandruff and skincare products, combining therapeutic effects with minimal side effects.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] CICLOPIROX OLAMINE - A HYDROXYPYRIDONE ANTIFUNGAL AGENT
    ABRAMS, BB
    HANEL, H
    HOEHLER, T
    CLINICS IN DERMATOLOGY, 1991, 9 (04) : 471 - 477
  • [2] Ciclopirox olamine: an antifungal alternative against cryptococcosis
    Oliveira, P. C.
    Medeiros, C. S. Q.
    Macedo, D. P. C.
    Andrade, S. L.
    Correia, M. T. A. L.
    Mesquita, S. D.
    Lima-Neto, R. G.
    Neves, R. P.
    LETTERS IN APPLIED MICROBIOLOGY, 2010, 51 (05) : 485 - 489
  • [3] INHIBITION OF NEUTROPHIL FUNCTION BY THE ANTIFUNGAL AGENT CICLOPIROX OLAMINE
    BAILEY, SC
    PRZEKOP, PA
    KURTZ, ES
    CLINICAL RESEARCH, 1993, 41 (02): : A494 - A494
  • [4] INHIBITION OF NEUTROPHIL FUNCTION BY THE ANTIFUNGAL AGENT CICLOPIROX OLAMINE
    BAILEY, SC
    PRZEKOP, PA
    KURTZ, ES
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 593 - 593
  • [5] Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal
    Sonthalia, Sidharth
    Agrawal, Mahima
    Sehgal, V. N.
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2019, 10 (04) : 481 - 485
  • [6] The anticancer mechanisms of ciclopirox olamine
    Shen, Tao
    Zhou, Hongyu
    Huang, Shile
    CANCER RESEARCH, 2013, 73 (08)
  • [7] CICLOPIROX OLAMINE, AND ANTIFUNGAL MODULATOR OF NEUTROPHIL FUNCTION AND INFILTRATE IN CUTANEOUS INFLAMMATION
    PRZEKOP, PA
    LEE, AA
    BAILEY, SC
    KURTZ, ES
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 593 - 593
  • [8] ONYCHOMYCOSIS AND AIDS - TREATMENT WITH TOPICAL CICLOPIROX OLAMINE
    DOMPMARTIN, D
    DOMPMARTIN, A
    DELUOL, AM
    COULAUD, JP
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1990, 29 (03) : 233 - 233
  • [9] Ciclopirox olamine directly scavenges hydroxyl radical
    Sato, Emiko
    Kohno, Masahiro
    Nakashima, Takuji
    Niwano, Yoshimi
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (01) : 15 - 18
  • [10] MODELLING AND BIOPHARMACEUTICAL EVALUATION OF CICLOPIROX OLAMINE GELS
    Mazurkevicute, Agne
    Ramanauskiene, Kristina
    Ivaskiene, Marija
    Grigonis, Aidas
    Briedis, Vitalis
    ACTA POLONIAE PHARMACEUTICA, 2017, 74 (02): : 543 - 549